Page last updated: 2024-12-05

3-methyladipic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-methyladipic acid : An alpha,omega-dicarboxylic acid that is adipic acid substituted with a methyl group at position C-3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12292
CHEBI ID68503
SCHEMBL ID20804
MeSH IDM0103317

Synonyms (43)

Synonym
(+)-3-methyladipic acid
hexanedioic acid, 3-methyl-
nsc22069
nsc-22069
3-methyladipic acid
3-methylhexanedioic acid
3058-01-3
beta-methyl-adipic acid
inchi=1/c7h12o4/c1-5(4-7(10)11)2-3-6(8)9/h5h,2-4h2,1h3,(h,8,9)(h,10,11
3-methyladipic acid, 99%
M0719
3-methyl-hexanedioic acid
LMFA01170095
3-methyl-adipic acid
AKOS000119442
nsc 22069
einecs 221-293-3
einecs 210-816-0
GEO-01740
61898-58-6
FT-0616118
CHEBI:68503
S6169
AKOS017343089
3-methyl adipic acid
SCHEMBL20804
hexanedioic acid,3-methyl-
W-200050
mfcd00002804
HY-113277
CS-0059490
FT-0772720
DTXSID40863090
Q27136984
AMY2449
D91380
(+)-3-methylhexanedioicacid
SB46018
3-methylhexanedioicacid
EN300-20312
SY049068
Z104477714
PD101961
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
alpha,omega-dicarboxylic acid
dicarboxylic fatty acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.98 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index34.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (25.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (62.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]